3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
11
Breast Neoplasms
10
Prostatic Neoplasms
7
Colorectal Neoplasms
7
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Hematopoietic and Lymphatic System Neoplasm
3
Hematologic Neoplasms
3
Advanced Malignant Solid Neoplasm
3
Skin Carcinoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Obesity-Related Malignant Neoplasm
2
Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Malignant Solid Neoplasm
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Carcinoma, Non-Small-Cell Lung
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Syndrome
1
Substance-Related Disorders
1
Spondylitis, Ankylosing
1
Rectal Neoplasms
1
Psoriasis
1
Primary Myelofibrosis
1
Interventions
durvalumab
3
abemaciclib
3
Fulvestrant
3
Cisplatin
3
ribociclib
2
pembrolizumab
2
palbociclib
2
Pemetrexed
2
Nivolumab
2
Letrozole
2
Carboplatin
2
Bevacizumab
2
Anastrozole
2
130-nm albumin-bound paclitaxel
2
selpercatinib
1
selinexor
1
repotrectinib
1
relatlimab
1
relacorilant
1
olaparib
1
gallium 68 PSMA-11
1
exemestane
1
enfortumab vedotin
1
elacestrant
1
darolutamide
1
cemiplimab
1
atezolizumab
1
Tamoxifen
1
Sunitinib
1
STX-478
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
Educational Status
×
90 days
×
Clear all
No trials found.